Sign in to view content

Expert Panel: Pegcetacoplan Safety

Andre J. Witkin, MD
David A. Eichenbaum, MD, FASRS
Samuel Anthony Minaker, MD, MSc
Janani Singaravelu, MS, MD
Sunir J. Garg, MD, FACS, FASRS

Video
Published 2024

Related

Fas Inhibition With ONL1204 for the Treatment of Geographic Atrophy: First-Time Results From a Phase 1b Study
Durga Borkar, MD
Annual Meeting Talks
2024
ReCLAIM-2: Phase 2 Trial of Subcutaneous Elamipretide in Patients with Noncentral Geographic Atrophy
Jeffrey S. Heier, MD
Annual Meeting Talks
2022
Inhibition of C1q Protects Photoreceptor Synapses in a Light Damage Model and Is a Potential Treatment for Geographic Atrophy
Patrick Dewey Williams, MD
Annual Meeting Talks
2022

Category: AMD-Non-Neovascular

See more